Video Thumbnail: 

Dr. David Agus stresses the importance of becoming an empowered patient.

A University of Alabama at Birmingham study has identified a gene deletion in nearly 25 percent of all glioblastoma cases that is believed to be responsible for poor patient outcomes. The discovery could lead to better diagnosis and targeted treatments with drugs that are currently available.

Video Thumbnail: 

The Promise of Research: Now and in the Future


Subscribe to RSS - Document
Share |

Join us in our fight for a cure!